Literature DB >> 24491486

Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.

Lu Wang1, Linlin Liu1, Hongjun Hao1, Feng Gao1, Xiao Liu1, Zhaoxia Wang1, Wei Zhang1, He Lv1, Yun Yuan2.   

Abstract

Myopathy with anti-signal recognition particle antibodies (SRP) is generally thought to be immune-mediated necrotic myopathy in previous studies. We report the clinical and histopathological features of myopathy with anti-SRP antibodies in Chinese patients. Muscle biopsy and immunoblots for myositis antibodies were carried out in 123 patients with idiopathic inflammatory myopathy. Among them, 16 (13.0%) patients had anti-SRP antibodies. Age of onset ranged from 24 to 77 years, and the disease began insidiously. Fourteen of 16 patients presented with chronic progression of proximal limb weakness, with 6 having myalgia. Serum creatine kinase levels ranged from 400 to 9082 IU/L. Muscle biopsies showed necrotic and/or regenerative muscle fibers in all 16, infiltrates of lymphocytes in 11 and morphological features of muscular dystrophy in 7. Eleven patients showed focal or diffuse major histocompatibility complex class 1 expression in sarcolemma or cytoplasm of muscle fibers, with 9 showing deposition of membrane attack complex in necrotic muscle fibers and 2 around capillaries. These findings indicate that anti-SRP antibodies are most likely to be related to IMNM. Myopathy with anti-SRP antibodies is not infrequent in Chinese patients with idiopathic inflammatory myopathy.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immunoblot; Myositis; Pathology; Signal recognition particle

Mesh:

Substances:

Year:  2014        PMID: 24491486     DOI: 10.1016/j.nmd.2014.01.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  11 in total

Review 1.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

Review 2.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

3.  [Clinical and pathological characteristics of immune mediated necrotizing myopathy].

Authors:  H X Yang; X L Tian; W Jiang; W L Li; Q Y Liu; Q L Peng; G C Wang; X Lu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

4.  Myositis: Are autoantibodies pathogenic in necrotizing myopathy?

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 5.  A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.

Authors:  Minoru Satoh; Shin Tanaka; Angela Ceribelli; S John Calise; Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

6.  Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.

Authors:  Cécile Picard; Thierry Vincent; Jean-Christophe Lega; Sophie Hue; Françoise Fortenfant; Daniela Lakomy; René-Louis Humbel; Joelle Goetz; Nicolas Molinari; Nathalie Bardin; Daniel Bertin; Catherine Johanet; Pascale Chretien; Sylvain Dubucquoi; Nathalie Streichenberger; Sophie Desplat-Jégo; Xavier Bossuyt; Jean Sibilia; Isabelle Abreu; Alain Chevailler; Nicole Fabien
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

7.  Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review.

Authors:  Andrea Aguilar-Vazquez; Efrain Chavarria-Avila; Oscar Pizano-Martinez; Alejandra Ramos-Hernandez; Lilia Andrade-Ortega; Edy-David Rubio-Arellano; Monica Vazquez-Del Mercado
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

8.  Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan.

Authors:  Hidenaga Kawasumi; Takahisa Gono; Yasushi Kawaguchi; Masataka Kuwana; Hirotaka Kaneko; Yasuhiro Katsumata; Sayuri Kataoka; Masanori Hanaoka; Hisashi Yamanaka
Journal:  Biomed Res Int       Date:  2016-01-26       Impact factor: 3.411

9.  Muscle Magnetic Resonance Imaging for the Differentiation of Multiple Acyl-CoA Dehydrogenase Deficiency and Immune-mediated Necrotizing Myopathy.

Authors:  Ya-Wen Zhao; Xiu-Juan Liu; Wei Zhang; Zhao-Xia Wang; Yun Yuan
Journal:  Chin Med J (Engl)       Date:  2018-01-20       Impact factor: 2.628

Review 10.  Bench to bedside review of myositis autoantibodies.

Authors:  Boaz Palterer; Gianfranco Vitiello; Alessia Carraresi; Maria Grazia Giudizi; Daniele Cammelli; Paola Parronchi
Journal:  Clin Mol Allergy       Date:  2018-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.